Published in Nat Commun on March 20, 2017
Competing memories of mitogen and p53 signalling control cell-cycle entry. Nature (2017) 0.82
Cell biology: The persistence of memory. Nature (2017) 0.75
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
T antigen is bound to a host protein in SV40-transformed cells. Nature (1979) 17.78
Participation of p53 protein in the cellular response to DNA damage. Cancer Res (1991) 16.00
p21 is a universal inhibitor of cyclin kinases. Nature (1993) 15.55
Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev (2001) 12.46
ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol (2008) 11.86
PCNA, the maestro of the replication fork. Cell (2007) 10.43
Modes of p53 regulation. Cell (2009) 9.31
p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer (2009) 9.21
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res (1994) 9.00
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (1994) 8.22
Stochastic simulation of chemical kinetics. Annu Rev Phys Chem (2007) 7.59
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell (1994) 7.05
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer (2008) 6.10
A neural network classifier capable of recognizing the patterns of all major subcellular structures in fluorescence microscope images of HeLa cells. Bioinformatics (2001) 5.84
Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature (1994) 4.96
Chromosome fragile sites. Annu Rev Genet (2007) 4.95
DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev (1994) 4.64
53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat Cell Biol (2011) 4.57
Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell (1995) 4.48
Systems Biology Toolbox for MATLAB: a computational platform for research in systems biology. Bioinformatics (2005) 4.38
Regulation of early events in chromosome replication. Curr Biol (2004) 3.97
Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature (2004) 3.73
Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1. J Cell Biol (2005) 3.69
Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem (2003) 3.68
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature (2004) 3.63
PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev (2008) 3.49
p53 dynamics control cell fate. Science (2012) 3.30
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc Natl Acad Sci U S A (1998) 3.26
Encoding and decoding cellular information through signaling dynamics. Cell (2013) 2.96
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev (2008) 2.71
Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc Natl Acad Sci U S A (1985) 2.65
CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem (2008) 2.63
Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J (1996) 2.61
Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol (2005) 2.44
Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell (2010) 2.40
The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell (2013) 2.37
Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res (2001) 2.37
Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell (2009) 2.05
Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol (1998) 2.02
Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev (2011) 1.95
Structural and thermodynamic analysis of human PCNA with peptides derived from DNA polymerase-delta p66 subunit and flap endonuclease-1. Structure (2004) 1.79
p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci U S A (1999) 1.79
p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene (1998) 1.76
The sorting direct method for stochastic simulation of biochemical systems with varying reaction execution behavior. Comput Biol Chem (2006) 1.59
ERCC1 and MUS81-EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis. Nat Cell Biol (2013) 1.49
Exploring the roles of noise in the eukaryotic cell cycle. Proc Natl Acad Sci U S A (2009) 1.46
Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol (2011) 1.46
BioModels: ten-year anniversary. Nucleic Acids Res (2014) 1.41
MUS81 promotes common fragile site expression. Nat Cell Biol (2013) 1.40
On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells. Biochemistry (2000) 1.35
Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene (2004) 1.29
Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene (1999) 1.23
Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Oncogene (1999) 1.23
Cell shape and the microenvironment regulate nuclear translocation of NF-κB in breast epithelial and tumor cells. Mol Syst Biol (2015) 1.11
DNA repair, genome stability and cancer: a historical perspective. Nat Rev Cancer (2015) 1.10
Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Oncogene (2002) 1.02
Start and the restriction point. Curr Opin Cell Biol (2013) 1.01
Stepwise activation of the ATR signaling pathway upon increasing replication stress impacts fragile site integrity. PLoS Genet (2013) 0.96
Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states. Proc Natl Acad Sci U S A (2014) 0.96
A Dynamical Framework for the All-or-None G1/S Transition. Cell Syst (2016) 0.88
Dynamics of CDKN1A in Single Cells Defined by an Endogenous Fluorescent Tagging Toolkit. Cell Rep (2016) 0.87
Global linking of cell tracks using the viterbi algorithm. IEEE Trans Med Imaging (2014) 0.85
CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing. Sci Rep (2016) 0.78
Cyclin Kinase-independent role of p21(CDKN1A) in the promotion of nascent DNA elongation in unstressed cells. Elife (2016) 0.76
Community control in cellular protein production: consequences for amino acid starvation. Philos Trans A Math Phys Eng Sci (2015) 0.80
RNAi screens for Rho GTPase regulators of cell shape and YAP/TAZ localisation in triple negative breast cancer. Sci Data (2017) 0.80
Proteomics profiling of interactome dynamics by colocalisation analysis (COLA). Mol Biosyst (2016) 0.75